FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and concerns a method of combination treatment of locally advanced stomach cancer. The method involves two courses of systemic polychemotherapy (PCT) followed by a radical surgery. The pre-operative PCT follows the scheme FOLFOX 6: oxaliplatin - 85 mg/m2 2-hour intravenous infusion in the 1st day; leucovorin - 200 mg/m2 2-hour intravenous infusion in the 1st and 2nd days; 5-fluorouracil - 400 mg/m2 intravenous bolus administration in the 1 st day then 5-fluorouracil - 2.4-3.0 g/m2 46-hour intravenous infusion; the course is repeated in 2-3 weeks.
EFFECT: invention provides improved remote results of the combined treatment of locally advanced stomach cancer ensured by reduced number of complications, as well as prevention of progression of tumour process and remote metastases.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OPERABLE OESOPHAGEAL CANCER | 2009 |
|
RU2424007C1 |
METHOD OF COMBINED TREATMENT OF PATIENTS WITH LOCALLY SPREAD RESECTABLE ESOPHAGEAL CANCER | 2009 |
|
RU2419391C1 |
METHOD FOR COMBINED TREATMENT OF OPERABLE STOMACH CANCER WITH HYPEREXPRESSION OF HER2/neu | 2020 |
|
RU2762319C1 |
METHOD OF TREATMENT OF PATIENTS WITH LOCAL NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2361580C2 |
METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED CARDIOESOPHAGEAL CANCER | 2021 |
|
RU2765845C1 |
METHOD FOR COMBINED TREATMENT OF COLON CANCER | 2023 |
|
RU2820567C1 |
METHOD FOR COMBINED TREATMENT OF OPERABLE STOMACH CANCER WITH A POSITIVE PDL STATUS | 2020 |
|
RU2756870C1 |
METHOD FOR APPLYING COMBINED TREATMENT OF PATIENTS FOR NON-SMALL-CELL PULMONARY CANCER OF III STAGE | 2004 |
|
RU2270706C2 |
METHOD FOR COMBINED TREATMENT OF SUPEROAMPULAR RECTUM CANCER | 2019 |
|
RU2723599C1 |
METHOD OF TREATING RECTAL CANCER WITH SYNCHRONOUS REMOTE METASTASES | 2011 |
|
RU2453345C1 |
Authors
Dates
2012-09-20—Published
2011-05-19—Filed